Clinical Trials Logo

Clinical Trial Summary

Overdose with potential deadly outcome is a serious problem among opioid abusers, not least in Norway. The annual death toll from overdose is about 250, twice the annual death toll from traffic accidents. Those who inject heroin or other opioids are considered to have the highest risk for death from overdose. To save lives, immediate treatment with a μ-opioid antidote such as naloxone is required. Usually naloxone is injected into a muscle or a blood vessel. Administration of naloxone via the nose has been suggested as an alternative for use by emergency teams and possibly also bystanders. This is not only an easier way to give naloxone, but would also eliminate the risk for needle stick injuries and blood contamination. A pilot study in this hospital has shown no significant side effects or adverse reaction. While significant benefits are expected from developing an adequately formulated naloxone nasal spray for pre-hospital use, the risks to participants are minimal. Therefore this preclinical study in healthy volunteers will be undertaken.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02158117
Study type Interventional
Source Norwegian University of Science and Technology
Contact
Status Completed
Phase Phase 1
Start date March 2014
Completion date November 2014

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04070521 - EEG Monitoring in the Emergency Department
Completed NCT04372238 - The Rhode Island Prescription and Illicit Drug Study N/A
Withdrawn NCT04391192 - Virtual Overdose Response N/A
Completed NCT02924454 - Effects of Lipid Emulsion on the Pharmacokinetic and Pharmacodynamic Properties of Metoprolol. Phase 4
Completed NCT02282306 - Phone Interview to Prevent Recurring Opioid Overdoses N/A
Not yet recruiting NCT01912573 - Nasal Naloxone for Narcotic Overdose Phase 4
Completed NCT04091659 - Use of Virtual Reality for Overdose Management Educational Trainings N/A
Recruiting NCT05517668 - Evaluation of the Efficacy of Fomepizole in the Treatment of Acetaminophen Overdose Phase 2
Completed NCT02572089 - Pharmacokinetic Evaluation of Intranasal and Intramuscular Naloxone in Healthy Volunteers Phase 1
Completed NCT02152397 - Safety and Health Intervention Project N/A
Active, not recruiting NCT05096429 - Preventing Overdose Using Information and Data From the Environment N/A
Recruiting NCT03845699 - Development of an Algorithm That Predicts Hypoventilation Due to an Opioid Overdose
Completed NCT03840018 - Effectiveness of a Postal Intervention to Improve the Use of PPI N/A
Recruiting NCT06327061 - Social Network Overdose Prevention and Education Intervention N/A
Completed NCT03087149 - Monitored vs Standard Supplementation of Vitamin D in Preterm Infants N/A
Active, not recruiting NCT05657106 - Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk N/A
Completed NCT02598856 - Bioavailability of Nasal Naloxone and Injected Naloxone Compared Phase 1
Recruiting NCT05146336 - CytOSorb TreatMent Of Critically Ill PatientS Registry
Not yet recruiting NCT02733822 - Buccal Versus Injectable Naloxone: a Phase I Healthy Volunteer Study Phase 1
Active, not recruiting NCT05308303 - AI to Improve Data From Danish Cardiac Arrest Registry